BALCX
Price
$40.03
Change
+$0.09 (+0.23%)
Updated
Sep 11 closing price
Net Assets
284.75B
ETNMX
Price
$15.02
Change
+$0.10 (+0.67%)
Updated
Sep 11 closing price
Net Assets
376.53M
Interact to see
Advertisement

BALCX vs ETNMX

BALCX vs ETNMX Comparison Chart in %
View a ticker or compare two or three
VS
BALCX vs. ETNMX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and ETNMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 285B vs. ETNMX (377M). ETNMX pays higher dividends than BALCX: ETNMX (1.82) vs BALCX (1.14). BALCX was incepted earlier than ETNMX: BALCX (26 years) vs ETNMX (11 years). BALCX (1.30) is less costly to investors than ETNMX (1.02). ETNMX is a more actively managed with annual turnover of: 55.00 vs. BALCX (50.00). BALCX has a lower initial minimum investment than ETNMX: BALCX (250) vs ETNMX (1000). BALCX annual gain was more profitable for investors over the last year : 5.86 vs. ETNMX (0.91). BALCX return over 5 years is better than : 27.49 vs. ETNMX (12.05).
BALCXETNMXBALCX / ETNMX
Total Expense Ratio1.301.02127%
Annual Report Gross Expense Ratio1.301.02127%
Fund Existence26 years11 years-
Gain YTD7.9595.961134%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets285B377M75,597%
Annual Yield % from dividends1.141.8263%
Returns for 1 year5.860.91643%
Returns for 3 years38.3125.72149%
Returns for 5 years27.4912.05228%
Returns for 10 years75.1973.29103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR3.920.07
+1.82%
Larimar Therapeutics
EGP198.121.42
+0.72%
EastGroup Properties
RAPP43.620.16
+0.37%
Rapport Therapeutics Inc.
MLAAU10.08N/A
N/A
Mountain Lake Acquisition Corp II
HRTX0.32-0.01
-2.11%
Heron Therapeutics